Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company engages in development, manufacturing, marketing, and sale of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services, as well as provides finance leasing services. The company was incorporated in 2006 and is based in Kwun Tong, Hong Kong.
Metrics to compare | 1889 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1889PeersSector | |
---|---|---|---|---|
P/E Ratio | −4.1x | 2.3x | −0.5x | |
PEG Ratio | 0.06 | 0.02 | 0.00 | |
Price/Book | 0.2x | 2.3x | 2.6x | |
Price / LTM Sales | 0.6x | 3.2x | 3.3x | |
Upside (Analyst Target) | - | 3.1% | 43.5% | |
Fair Value Upside | Unlock | −7.1% | 6.8% | Unlock |